myxoid liposarcoma | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

4,932 results for “myxoid liposarcoma”

Pembrolizumab Shows Promise in NSCLC and Other Cancers, New Subcutaneous Formulation Advances

Adaptimmune's Lete-cel Shows Promise in Sarcoma, Nearing FDA Submission

Robust Pipeline for Ewing Sarcoma Treatment: 25+ Companies Advancing Novel Therapies

Adaptimmune Undergoes Major Leadership Restructuring Following Nasdaq Delisting and Asset Divestiture

MAGEA4-Targeted Therapies Show Promise in Solid Tumors Beyond Synovial Sarcoma

FDA Clears IND for Medigene's TCR-T Therapy MDG1015 in Advanced Solid Tumors

Adaptimmune's Lete-cel Receives FDA Breakthrough Therapy Designation for MRCLS

Adaptimmune's Lete-cel Shows Promise in Sarcoma, Nearing Potential Approval

Medigene Advances TCR-T Therapies with FDA Clearance and Strategic Partnerships

Adaptimmune's Lete-cel Shows Promise in Advanced Sarcomas, BLA Submission Planned

Page 1 of 21